EMILY MCENERNEY: Open Payments
NPI 1982477709 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,566 in 67 payments from 15 companies in 2025. Trend: 2023 $65 · 2024 $1,890 · 2025 $1,566
Food & beverage: $1,480Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $348 |
| ABBVIE INC. | 17 | $270 |
| Amgen Inc. | 5 | $158 |
| Regeneron Healthcare Solutions, Inc. | 4 | $156 |
| Lilly USA, LLC | 5 | $107 |
| Arcutis Biotherapeutics, Inc. | 5 | $96 |
| UCB, Inc. | 3 | $85 |
| Janssen Biotech, Inc. | 4 | $79 |
| Incyte Corporation | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
Products named: DUPIXENT, RINVOQ, OTEZLA, TALTZ, SKYRIZI, Zoryve, Bimzelx, TREMFYA.
Industry payments across FL — which companies pay providers there.
